Discover Novartis' Q1 EPS soars 17% to $1.80, surpassing estimates. Sales hit $11.83B, up 10%. Entresto sales surge 36%, Cosentyx up 25%. CEO Vas Narasimhan bullish on mid & long-term growth.
Dive into PepsiCo Inc's Q1 FY24 results: a 2.3% sales uptick to $18.250 billion, exceeding analyst forecasts. While Frito-Lay North America saw a 2% revenue boost, Quaker Foods North America faced a 24% decline. Latin America experienced a 16% surge, and Europe sales rose by 3%. With a gross profit increase to $10 billion and an adjusted EPS of $1.61 surpassing estimates, PepsiCo demonstrates resilience amidst varied regional performances.
Full-Year 2024 GuidanceMSCI's guidance for the year ending December 31, 2024 ("Full-Year 2024") is based on assumptions about a number of factors, in particular related to macroeconomic factors and the capital markets.